Can Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?

Figure 1

Molecular biomarkers in PDAC. Most of the molecular biomarkers may have multiple functions. Some prognosis biomarkers could be used both for diagnosis (HOTAIR, PVT-1, GAS-5, and KRAS) and for predicting treatment response (SPARC, GRP78, TWIST, SNAIL, and miR-21).